FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Shrinivas Kulkarni

Research Profile

Living Beings

Concepts & Ideas

Activities & Behaviors

Disorders

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
Shrinivas K Kulkarni; Kiran Kumar Akula; Jayant Deshpande
Evaluation of antidepressant-like activity of novel water-soluble curcumin formulations and St. John's wort in behavioral paradigms of despair.
Mahendra Bishnoi; Kanwaljit Chopra; Lu Rongzhu; Shrinivas K Kulkarni
Protective effect of curcumin and its combination with piperine (bioavailability enhancer) against haloperidol-associated neurotoxicity: cellular and neurochemical evidence.
Raghuvir S Pissurlenkar; Ashish Dhir; Satinder V Kessar; Shrinivas K Kulkarni; Evans C Coutinho
An activity model for novel antidepressants that interact with the serotonin transporter (SERT).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Shrinivas Kulkarni (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Shrinivas K Kulkarni; Kiran Kumar Akula; Jayant Deshpande
Evaluation of antidepressant-like activity of novel water-soluble curcumin formulations and St. John's wort in behavioral paradigms of despair.
Pharmacology 2012;89(1-2):83-90.
2011: Mahendra Bishnoi; Kanwaljit Chopra; Lu Rongzhu; Shrinivas K Kulkarni
Protective effect of curcumin and its combination with piperine (bioavailability enhancer) against haloperidol-associated neurotoxicity: cellular and neurochemical evidence.
Neurotoxicity research 2011;20(3):215-25.
2011: Raghuvir S Pissurlenkar; Ashish Dhir; Satinder V Kessar; Shrinivas K Kulkarni; Evans C Coutinho
An activity model for novel antidepressants that interact with the serotonin transporter (SERT).
Central nervous system agents in medicinal chemistry 2011;11(3):228-37.
2011: Kavita Pabreja; Kamal Dua; Saurabh Sharma; Satyanarayana S V Padi; Shrinivas K Kulkarni
Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms.
European journal of pharmacology 2011;661(1-3):15-21.
2010: Amit Gupta; Anil Kumar; Shrinivas K Kulkarni
Licofelone attenuates MPTP-induced neuronal toxicity: behavioral, biochemical and cellular evidence.
Inflammopharmacology 2010;18(5):223-32.
2010: Amit Gupta; Ashish Dhir; Anil Kumar; Shrinivas K Kulkarni
Effect of preferential cyclooxygenase-2 (COX-2) inhibitor against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced striatal lesions in rats: behavioral, biochemical and histological evidences.
Indian journal of experimental biology 2010;48(6):577-85.
2010: Shrinivas K Kulkarni; Ashish Dhir
An overview of curcumin in neurological disorders.
Indian journal of pharmaceutical sciences 2010;72(2):149-54.
2010: Shrinivas K Kulkarni; Ashish Dhir
Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders.
Phytotherapy research : PTR 2010;24(3):317-24.
2010: Xing Guangwei; Lu Rongzhu; Xu Wenrong; Wang Suhua; Zhao Xiaowu; Wang Shizhong; Zhang Ye; Michael Aschner; Shrinivas K Kulkarni; Mahendra Bishnoi
Curcumin pretreatment protects against acute acrylonitrile-induced oxidative damage in rats.
Toxicology 2010;267(1-3):140-6.
2009: Amit Gupta; Ashish Dhir; ANIL KUMAR; Shrinivas K Kulkarni
Protective effect of cyclooxygenase (COX)-inhibitors against drug-induced catatonia and MPTP-induced striatal lesions in rats.
Pharmacology, biochemistry, and behavior 2009;94(2):219-26.
2009: Kiran Kumar Akula; Ashish Dhir; Shrinivas K Kulkarni
Effect of various antiepileptic drugs in a pentylenetetrazol-induced seizure model in mice.
Methods and findings in experimental and clinical pharmacology 2009;31(7):423-32.
2009: Shrinivas K Kulkarni; Ashish Dhir
sigma-1 receptors in major depression and anxiety.
Expert review of neurotherapeutics 2009;9(7):1021-34.
2009: Shrinivas K Kulkarni; Ashish Dhir
Current investigational drugs for major depression.
Expert opinion on investigational drugs 2009;18(6):767-88.
2009: Mohit Kumar Bhutani; Mahendra Bishnoi; Shrinivas K Kulkarni
Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes.
Pharmacology, biochemistry, and behavior 2009;92(1):39-43.
2009: Shrinivas K Kulkarni; Mahendra Bishnoi; Kanwaljit Chopra
In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration.
Indian journal of experimental biology 2009;47(2):91-7.
2009: Shrinivas K Kulkarni; Ashish Dhir
Cyclooxygenase in epilepsy: from perception to application.
Drugs of today (Barcelona, Spain : 1998) 2009;45(2):135-54.
2008: Satyanarayana S V Padi; Shrinivas K Kulkarni
Minocycline prevents the development of neuropathic pain, but not acute pain: possible anti-inflammatory and antioxidant mechanisms.
European journal of pharmacology 2008;601(1-3):79-87.
2008: Ashish Dhir; Shrinivas K Kulkarni
New therapeutic promises in the treatment of depression and schizophrenia.
Drug news & perspectives 2008;21(10):581-92.
2008: Shrinivas K Kulkarni; Mohit Kumar Bhutani; Mahendra Bishnoi
Antidepressant activity of curcumin: involvement of serotonin and dopamine system.
Psychopharmacology 2008;201(3):435-42.
2008: Ashish Dhir; Shrinivas K Kulkarni
Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors.
Neuroscience letters 2008;445(1):83-8.
2008: Kiran Kumar Akula; Manninder Kaur; Shrinivas K Kulkarni
Estimation of adenosine and its major metabolites in brain tissues of rats using high-performance thin-layer chromatography-densitometry.
Journal of chromatography. A 2008;1209(1-2):230-7.
2008: Ashish Dhir; Shrinivas K Kulkarni
Antidepressant-like effect of 17beta-estradiol: involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems.
Canadian journal of physiology and pharmacology 2008;86(10):726-35.
2008: Kiran Kumar Akula; Manninder Kaur; Mahendra Bishnoi; Shrinivas K Kulkarni
Development and validation of an RP-HPLC method for the estimation of adenosine and related purines in brain tissues of rats.
Journal of separation science 2008;31(18):3139-47.
2008: Shrinivas K Kulkarni; Kulwinder Singh; Mahendra Bishnoi
Comparative behavioural profile of newer antianxiety drugs on different mazes.
Indian journal of experimental biology 2008;46(9):633-8.
2008: Mahendra Bishnoi; Kanwaljit Chopra; Shrinivas K Kulkarni
Protective effect of L-type calcium channel blockers against haloperidol-induced orofacial dyskinesia: a behavioural, biochemical and neurochemical study.
Neurochemical research 2008;33(9):1869-80.
2008: Mahendra Bishnoi; Kanwaljit Chopra; Shrinivas K Kulkarni
Activation of striatal inflammatory mediators and caspase-3 is central to haloperidol-induced orofacial dyskinesia.
European journal of pharmacology 2008;590(1-3):241-5.
2008: Ashish Dhir; Shrinivas K Kulkarni
Possible involvement of sigma-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor.
Fundamental & clinical pharmacology 2008;22(4):387-94.
2008: Mahendra Bishnoi; Kanwaljit Chopra; Shrinivas K Kulkarni
Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
Progress in neuro-psychopharmacology & biological psychiatry 2008;32(6):1473-8.
2008: Shrinivas K Kulkarni; Ashish Dhir
On the mechanism of antidepressant-like action of berberine chloride.
European journal of pharmacology 2008;589(1-3):163-72.
2008: Shrinivas K Kulkarni; Ashish Dhir
Withania somnifera: an Indian ginseng.
Progress in neuro-psychopharmacology & biological psychiatry 2008;32(5):1093-105.
2008: Kiran Kumar Akula; Ashish Dhir; Shrinivas K Kulkarni
Nitric oxide signaling pathway in the anti-convulsant effect of adenosine against pentylenetetrazol-induced seizure threshold in mice.
European journal of pharmacology 2008;587(1-3):129-34.
2008: Shrinivas K Kulkarni; Kiran Kumar Akula; Ashish Dhir
Effect of Withania somnifera Dunal root extract against pentylenetetrazol seizure threshold in mice: possible involvement of GABAergic system.
Indian journal of experimental biology 2008;46(6):465-9.
2008: Ashish Dhir; Shrinivas K Kulkarni
Venlafaxine reverses chronic fatigue-induced behavioral, biochemical and neurochemical alterations in mice.
Pharmacology, biochemistry, and behavior 2008;89(4):563-71.
2008: Ashish Dhir; Kiran Kumar Akula; Shrinivas K Kulkarni
Rofecoxib potentiates the anticonvulsant effect of topiramate.
Inflammopharmacology 2008;16(2):83-6.
2008: Ashish Dhir; Kiran Kumar Akula; Shrinivas K Kulkarni
Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
Progress in neuro-psychopharmacology & biological psychiatry 2008;32(3):835-43.
2008: Ashish Dhir; Shrinivas K Kulkarni
Possible involvement of nitric oxide (NO) signaling pathway in the antidepressant-like effect of MK-801(dizocilpine), a NMDA receptor antagonist in mouse forced swim test.
Indian journal of experimental biology 2008;46(3):164-70.
2008: Mahendra Bishnoi; Kanwaljit Chopra; Shrinivas K Kulkarni
Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
Progress in neuro-psychopharmacology & biological psychiatry 2008;32(2):451-61.
2008: Shrinivas K Kulkarni; Vijay Pal Singh
Positioning dual inhibitors in the treatment of pain and inflammatory disorders.
Inflammopharmacology 2008;16(1):1-15.
2008: Mahendra Bishnoi; Kanwaljit Chopra; Shrinivas K Kulkarni
Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
Pharmacology, biochemistry, and behavior 2008;88(4):511-22.
2008: Mahendra Bishnoi; Kanwaljit Chopra; Shrinivas K Kulkarni
Modulatory effect of neurosteroids in haloperidol-induced vacuous chewing movements and related behaviors.
Psychopharmacology 2008;196(2):243-54.
2008: Shrinivas K Kulkarni; Vijay P Singh
Licofelone: the answer to unmet needs in osteoarthritis therapy?
Current rheumatology reports 2008;10(1):43-8.
2008: Kiran Kumar Akula; Ashish Dhir; Shrinivas K Kulkarni
Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: possible involvement of adenosinergic mechanism.
Epilepsy research 2008;78(1):60-70.
2007: Kiran Kumar Akula; Ashish Dhir; Shrinivas K Kulkarni
Systemic administration of adenosine ameliorates pentylenetetrazol-induced chemical kindling and secondary behavioural and biochemical changes in mice.
Fundamental & clinical pharmacology 2007;21(6):583-94.
2007: Ashish Dhir; Pattipati S Naidu; Shrinivas K Kulkarni
Neuroprotective effect of nimesulide, a preferential COX-2 inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical parameters in mice.
Seizure : the journal of the British Epilepsy Association 2007;16(8):691-7.
2007: Mahendra Bishnoi; Kanwaljit Chopra; Shrinivas K Kulkarni
U-74500A (lazaroid), a 21-aminosteroid attenuates neuroleptic-induced orofacial dyskinesia.
Methods and findings in experimental and clinical pharmacology 2007;29(9):601-5.
2007: Mahendra Bishnoi; Kanwaljit Chopra; Shrinivas K Kulkarni
Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
Fundamental & clinical pharmacology 2007;21(5):521-9.
2007: Kiran Kumar Akula; Ashish Dhir; Mahendra Bishnoi; Shrinivas K Kulkarni
Effect of systemic administration of adenosine on brain adenosine levels in pentylenetetrazol-induced seizure threshold in mice.
Neuroscience letters 2007;425(1):39-42.
2007: Ashish Dhir; Shrinivas K Kulkarni
Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
Brain research bulletin 2007;74(1-3):58-65.
2007: Shrinivas K Kulkarni; Ashish Dhir
Effect of various classes of antidepressants in behavioral paradigms of despair.
Progress in neuro-psychopharmacology & biological psychiatry 2007;31(6):1248-54.
2007: Shrinivas K Kulkarni; Ashish Dhir
Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride.
European journal of pharmacology 2007;569(1-2):77-83.
2007: Kiran Kumar Akula; Ashish Dhir; Shrinivas K Kulkarni
Pro-convulsant effect of cefazolin sodium against pentylenetetrazol- or picrotoxin-induced convulsions in mice.
Indian journal of experimental biology 2007;45(8):720-5.
2007: Ashish Dhir; Shrinivas K Kulkarni
Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
European journal of pharmacology 2007;568(1-3):177-85.
2007: Shrinivas K Kulkarni; Anupama Kaushal; Ashish Dhir
Effect of withdrawal of diazepam or morphine treatment on gastric motility (charcoal meal test) in mice: possible role of different central and peripheral receptors.
Indian journal of experimental biology 2007;45(7):642-8.
2007: Mahendra Bishnoi; Kanwaljit Chopra; Shrinivas K Kulkarni
Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
Progress in neuro-psychopharmacology & biological psychiatry 2007;31(5):1130-8.
2007: Ashish Dhir; Shrinivas K Kulkarni
Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine.
Neuroscience letters 2007;420(3):204-8.
2007: Shrinivas K Kulkarni; K Singh; Mahendra Bishnoi
Elevated zero maze: a paradigm to evaluate antianxiety effects of drugs.
Methods and findings in experimental and clinical pharmacology 2007;29(5):343-8.
2007: Ashish Dhir; Shrinivas K Kulkarni
Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice.
Progress in neuro-psychopharmacology & biological psychiatry 2007;31(4):921-5.
2007: Shrinivas K Kulkarni; Kulwinder Singh; Mahendra Bishnoi
Involvement of adenosinergic receptors in anxiety related behaviours.
Indian journal of experimental biology 2007;45(5):439-43.
2007: Mahendra Bishnoi; Kanwaljit Chopra; Shrinivas K Kulkarni
Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia.
Methods and findings in experimental and clinical pharmacology 2007;29(3):211-6.
2007: Mahendra Bishnoi; Kanwaljit Chopra; Shrinivas K Kulkarni
Theophylline, adenosine receptor antagonist prevents behavioral, biochemical and neurochemical changes associated with an animal model of tardive dyskinesia.
Pharmacological reports : PR 2007;59(2):181-91.
2007: sameer sharma; Kanwaljit Chopra; Shrinivas K Kulkarni
Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha.
Phytotherapy research : PTR 2007;21(3):278-83.
2007: Mahendra Bishnoi; Anil Kumar; Kanwaljit Chopra; Shrinivas K Kulkarni
Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia.
Indian journal of experimental biology 2007;45(2):175-9.
2007: sameer sharma; Shrinivas K Kulkarni; Kanwaljit Chopra
Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain.
Fundamental & clinical pharmacology 2007;21(1):89-94.
2007: Ashish Dhir; Shrinivas K Kulkarni
Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test.
Pharmacology 2007;80(4):239-43.
2007: Mahendra Bishnoi; Kanwaljit Chopra; Shrinivas K Kulkarni
Protective effect of adenosine reuptake inhibitors in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
Pharmacology 2007;79(3):171-83.
2007: Shrinivas K Kulkarni; Vijay Pal Singh
Licofelone--a novel analgesic and anti-inflammatory agent.
Current topics in medicinal chemistry 2007;7(3):251-63.
2007: sameer sharma; Kanwaljit Chopra; Shrinivas K Kulkarni; Javed N Agrewala
Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway.
Clinical and experimental immunology 2007;147(1):155-63.
2007: Mahendra Bishnoi; Chandrashekhar S Patil; ANIL KUMAR; Shrinivas K Kulkarni
Co-administration of acetyl-11-keto-beta-boswellic acid, a specific 5-lipoxygenase inhibitor, potentiates the protective effect of COX-2 inhibitors in kainic acid-induced neurotoxicity in mice.
Pharmacology 2007;79(1):34-41.
2006: Ashish Dhir; Pattipati S Naidu; Shrinivas K Kulkarni
Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: Possible mechanism of action.
Progress in neuro-psychopharmacology & biological psychiatry 2006;30(8):1478-85.
2006: Mahendra Bishnoi; Kanwaljit Chopra; Shrinivas K Kulkarni
Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
European journal of pharmacology 2006;552(1-3):55-66.
2006: Ashish Dhir; Shrinivas K Kulkarni
Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor potentiates the anticonvulsant activity of tiagabine against pentylenetetrazol-induced convulsions in mice.
Inflammopharmacology 2006;14(5-6):222-5.
2006: sameer sharma; Shrinivas K Kulkarni; Kanwaljit Chopra
Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats.
Clinical and experimental pharmacology & physiology 2006;33(10):940-5.
2006: sameer sharma; Shrinivas K Kulkarni; Kanwaljit Chopra
Resveratrol, a polyphenolic phytoalexin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats.
Indian journal of experimental biology 2006;44(7):566-9.
2006: Anil Kumar; Shrinivas K Kulkarni
Protective effect of BR-16A, a polyherbal preparation against social isolation stress: possible GABAergic mechanism.
Phytotherapy research : PTR 2006;20(7):538-41.
2006: Ashish Dhir; Pattipati S Naidu; Shrinivas K Kulkarni
Effect of rofecoxib, a cyclo-oxygenase-2 inhibitor, on various biochemical parameters of brain associated with pentylenetetrazol-induced chemical kindling in mice.
Fundamental & clinical pharmacology 2006;20(3):255-61.
2006: Chandrashekhar S Patil; Vijay Pal Singh; Shrinivas K Kulkarni
Modulatory effect of sildenafil in diabetes and electroconvulsive shock-induced cognitive dysfunction in rats.
Pharmacological reports : PR 2006;58(3):373-80.
2006: Ashish Dhir; Pattipati S Naidu; Shrinivas K Kulkarni
Effect of cyclooxygenase-2 (COX-2) inhibitors in various animal models (bicuculline, picrotoxin, maximal electroshock-induced convulsions) of epilepsy with possible mechanism of action.
Indian journal of experimental biology 2006;44(4):286-91.
2006: Ashish Dhir; Satyanarayana S V Padi; Pattipati S Naidu; Shrinivas K Kulkarni
Protective effect of naproxen (non-selective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) on immobilization stress-induced behavioral and biochemical alterations in mice.
European journal of pharmacology 2006;535(1-3):192-8.
2006: Satyanarayana S V Padi; Pattipati S Naidu; Shrinivas K Kulkarni
Involvement of peripheral prostaglandins in formalin-induced nociceptive behaviours in the orofacial area of rats.
Inflammopharmacology 2006;14(1-2):57-61.
2006: Vijay Pal Singh; Chandrashekhar S Patil; Shrinivas K Kulkarni
Analysis of interaction between etoricoxib and tramadol against mechanical hyperalgesia of spinal cord injury in rats.
Life sciences 2006;78(11):1168-74.
2006: Mahendra Bishnoi; Chandrashekhar S Patil; ANIL KUMAR; Shrinivas K Kulkarni
Potentiation of antinociceptive effect of NSAIDs by a specific lipooxygenase inhibitor, acetyl 11-keto-beta boswellic acid.
Indian journal of experimental biology 2006;44(2):128-32.
2006: Vijay Pal Singh; Chandrashekhar S Patil; Shrinivas K Kulkarni
Anti-inflammatory effect of licofelone against various inflammatory challenges.
Fundamental & clinical pharmacology 2006;20(1):65-71.
2006: Pattipati S Naidu; amanpreet Singh; Shrinivas K Kulkarni
Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction.
Phytotherapy research : PTR 2006;20(2):140-6.
2006: Chandrashekhar Deshpande; Ashish Dhir; Shrinivas K Kulkarni
Antagonistic activity of ascorbic acid (vitamin C) on dopaminergic modulation: apomorphine-induced stereotypic behavior in mice.
Pharmacology 2006;77(1):38-45.
2006: Anil Kumar; Shrinivas K Kulkarni
Effect of BR-16A (Mentat), a polyherbal formulation on drug-induced catalepsy in mice.
Indian journal of experimental biology 2006;44(1):45-8.
2006: sameer sharma; Muragundla Anjaneyulu; Shrinivas K Kulkarni; Kanwaljit Chopra
Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats.
Pharmacology 2006;76(2):69-75.
2005: Vijay Pal Singh; Chandrashekhar S Patil; Manish Kumar; Shrinivas K Kulkarni
Effect of 5-lipoxygenase inhibitor against lipopolysaccharide-induced hypothermia in mice.
Indian journal of experimental biology 2005;43(12):1150-5.
2005: Ashish Dhir; Pattipati S Naidu; Shrinivas K Kulkarni
Protective effect of cyclooxygenase-2 (COX-2) inhibitors but not non-selective cyclooxygenase (COX)-inhibitors on ethanol withdrawal-induced behavioural changes.
Addiction biology 2005;10(4):329-35.
2005: Dipesh Joshi; Pattipati S Naidu; amanpreet Singh; Shrinivas K Kulkarni
Reversal of triazolam tolerance and withdrawal-induced hyperlocomotor activity and anxiety by bupropion in mice.
Pharmacology 2005;75(2):93-7.
2005: Mahendra Bishnoi; Chandrashekhar S Patil; ANIL KUMAR; Shrinivas K Kulkarni
Protective effects of nimesulide (COX Inhibitor), AKBA (5-LOX Inhibitor), and their combination in aging-associated abnormalities in mice.
Methods and findings in experimental and clinical pharmacology 2005;27(7):465-70.
2005: Ashish Dhir; Pattipati S Naidu; Shrinivas K Kulkarni
Effect of naproxen, a non-selective cyclo-oxygenase inhibitor, on pentylenetetrazol-induced kindling in mice.
Clinical and experimental pharmacology & physiology 2005;32(7):574-84.
2005: Vijay Pal Singh; Chandrashekhar S Patil; Shrinivas K Kulkarni
Differential effect of zileuton, a 5-lipoxygenase inhibitor, against nociceptive paradigms in mice and rats.
Pharmacology, biochemistry, and behavior 2005;81(3):433-9.
2005: sameer sharma; rameshkumar mohanlal gupta; Shrinivas K Kulkarni
Possible analgesic and anti-inflammatory interactions of aspartame with opioids and NSAIDs.
Indian journal of experimental biology 2005;43(6):498-502.
2005: Vijay Pal Singh; Chandrashekhar S Patil; Shrinivas K Kulkarni
Effect of licofelone against mechanical hyperalgesia and cold allodynia in the rat model of incisional pain.
Pharmacological reports : PR 2005;57(3):380-4.
2005: Rajesh Goel; J S Thind; C S Bal; Mohinder P Mahajan; Shrinivas K Kulkarni
Hypocholesterolemic activity of some novel azetidin-2-ones in diet and diabetes induced hypercholesterolemia in rats.
Die Pharmazie 2005;60(5):369-74.
2005: Sarka Lehtonen; Amanpreet Singh; Tiina Kääriäinen; Heli Taari; Shrinivas K Kulkarni; Pekka T Männistö
Failure of FK506 (tacrolimus) to alleviate apomorphine-induced circling in rat Parkinson model in spite of some cytoprotective effects in SH-SY5Y dopaminergic cells.
Brain research 2005;1038(1):83-91.
2005: Vijay Pal Singh; Chandrashekhar S Patil; Shrinivas K Kulkarni
Effect of licofelone against NSAIDs-induced gastrointestinal ulceration and inflammation.
Indian journal of experimental biology 2005;43(3):247-53.
2005: Chandrashekhar S Patil; Vijay Pal Singh; rameshkumar mohanlal gupta; Shrinivas K Kulkarni
Inhibitory effect of sildenafil on gastrointestinal smooth muscle: role of NO-cGMP transduction pathway.
Indian journal of experimental biology 2005;43(2):167-71.
2005: Chandrashekhar S Patil; Vijay Pal Singh; Shrinivas K Kulkarni
Peripheral and central activation of nitric oxide-cyclic GMP pathway by sildenafil.
Inflammopharmacology 2005;13(5-6):467-78.
2005: D Joshi; Pattipati S Naidu; amanpreet Singh; Shrinivas K Kulkarni
Protective effect of quercetin on alcohol abstinence-induced anxiety and convulsions.
Journal of medicinal food 2005;8(3):392-6.
2005: Rajesh Goel; amanpreet Singh; Pattipati S Naidu; Mohinder P Mahajan; Shrinivas K Kulkarni
PASS assisted search and evaluation of some azetidin-2-ones as C.N.S. active agents.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 2005;8(2):182-9.
2005: Satyanarayana S V Padi; Shrinivas K Kulkarni
Role of cyclooxygenase-2 in lipopolysaccharide-induced hyperalgesia in formalin test.
Indian journal of experimental biology 2005;43(1):53-60.
2004: Shrinivas K Kulkarni; Chandrashekhar S Patil
Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects.
Methods and findings in experimental and clinical pharmacology 2004;26(10):789-99.
2004: Chandrashekhar S Patil; Vijay Pal Singh; Sukhjeet Singh; Shrinivas K Kulkarni
Modulatory effect of the PDE-5 inhibitor sildenafil in diabetic neuropathy.
Pharmacology 2004;72(3):190-5.
2004: D Joshi; amanpreet Singh; Pattipati S Naidu; Shrinivas K Kulkarni
Protective effect of bupropion on morphine tolerance and dependence in mice.
Methods and findings in experimental and clinical pharmacology 2004;26(8):623-6.
2004: Satyanarayana S V Padi; Shrinivas K Kulkarni
Differential effects of naproxen and rofecoxib on the development of hypersensitivity following nerve injury in rats.
Pharmacology, biochemistry, and behavior 2004;79(2):349-58.
2004: Vijay Pal Singh; Chandrashekhar S Patil; rameshkumar mohanlal gupta; Shrinivas K Kulkarni
Aggravation of inflammatory bowel disease by cyclooxygenase-2 inhibitors in rats.
Pharmacology 2004;72(2):77-84.
2004: Vijay Pal Singh; Chandrashekhar S Patil; Shrinivas K Kulkarni
Effect of 5-lipoxygenase inhibition on events associated with inflammatory bowel disease in rats.
Indian journal of experimental biology 2004;42(7):667-73.
2004: Padi S V Satyanarayana; rameshkumar mohanlal gupta; Amarjit Singh; Shrinivas K Kulkarni
Isobolographic analysis of interaction between cyclooxygenase inhibitors and tramadol in acetic acid-induced writhing in mice.
Progress in neuro-psychopharmacology & biological psychiatry 2004;28(4):641-9.
2004: Pattipati S Naidu; Shrinivas K Kulkarni
Quercetin, a bioflavonoid, reverses haloperidol-induced catalepsy.
Methods and findings in experimental and clinical pharmacology 2004;26(5):323-6.
2004: Shrinivas K Kulkarni; Chandrashekhar S Patil; rameshkumar mohanlal gupta; Amarjit Singh
Modulatory effect of diclofenac on antispasmodic effect of pitofenone in cholinergic spasm.
Indian journal of experimental biology 2004;42(6):567-9.
2004: Anil Kumar; Shrinivas K Kulkarni
On the sleep promoting effects of BR-16A: interaction with GABAergic modulators.
Indian journal of experimental biology 2004;42(5):448-51.
2004: Satyanarayana S V Padi; rameshkumar mohanlal gupta; Sukhjeet Singh; Shrinivas K Kulkarni
Pharmacological profile of parecoxib: a novel, potent injectable selective cyclooxygenase-2 inhibitor.
European journal of pharmacology 2004;491(1):69-76.
2004: Rajesh Goel; Mohinder P Mahajan; Shrinivas K Kulkarni
Evaluation of anti-hyperglycemic activity of some novel monocyclic beta lactams.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 2004;7(1):80-3.
2004: Chandrashekhar S Patil; rameshkumar mohanlal gupta; Vijay Pal Singh; Shrinivas K Kulkarni
Cholinergic-NO-cGMP mediation of sildenafil-induced antinociception.
Indian journal of experimental biology 2004;42(4):361-7.
2004: Pattipati S Naidu; amanpreet Singh; Shrinivas K Kulkarni
Reversal of reserpine-induced orofacial dyskinesia and cognitive dysfunction by quercetin.
Pharmacology 2004;70(2):59-67.
2004: Vijay Pal Singh; Chandrashekhar S Patil; Shrinivas K Kulkarni
Effect of zileuton in radicular pain induced by herniated nucleus pulposus in rats.
Inflammopharmacology 2004;12(2):189-95.
2004: Padi S V Satyanarayana; rameshkumar mohanlal gupta; Sukhjeet Singh; Shrinivas K Kulkarni
Effect of selective inhibition of cyclooxygenase-2 on lipopolysaccharide-induced hyperalgesia.
Inflammopharmacology 2004;12(1):57-68.
2003: amanpreet Singh; Gaurav Kumar; Pattipati S Naidu; Shrinivas K Kulkarni
Antinociceptive action of FK506 in mice.
Indian journal of experimental biology 2003;41(12):1405-9.
2003: Pattipati S Naidu; amanpreet Singh; Shrinivas K Kulkarni
D2-dopamine receptor and alpha2-adrenoreceptor-mediated analgesic response of quercetin.
Indian journal of experimental biology 2003;41(12):1400-4.
2003: Chandrashekhar S Patil; rameshkumar mohanlal gupta; Amarjit Singh; Shrinivas K Kulkarni
Modulatory effect of cyclooxygenase inhibitors on sildenafil-induced antinociception.
Pharmacology 2003;69(4):183-9.
2003: amanpreet Singh; Pattipati S Naidu; Shrinivas K Kulkarni
FK506 as effective adjunct to L-dopa in reserpine-induced catalepsy in rats.
Indian journal of experimental biology 2003;41(11):1264-8.
2003: amanpreet Singh; Pattipati S Naidu; Shrinivas K Kulkarni
Reversal of aging and chronic ethanol-induced cognitive dysfunction by quercetin a bioflavonoid.
Free radical research 2003;37(11):1245-52.
2003: Vijay Pal Singh; Chandrashekhar S Patil; Naveen K Jain; Amarjit Singh; Shrinivas K Kulkarni
Paradoxical effects of opioid antagonist naloxone on SSRI-induced analgesia and tolerance in mice.
Pharmacology 2003;69(3):115-22.
2003: Chandrashekhar S Patil; Vijay Pal Singh; P S V Satyanarayan; rameshkumar mohanlal gupta; Amarjit Singh; Shrinivas K Kulkarni
Protective effect of flavonoids against aging- and lipopolysaccharide-induced cognitive impairment in mice.
Pharmacology 2003;69(2):59-67.
2003: amanpreet Singh; Pattipati S Naidu; Shrinivas K Kulkarni
Possible antioxidant and neuroprotective mechanisms of FK506 in attenuating haloperidol-induced orofacial dyskinesia.
European journal of pharmacology 2003;477(2):87-94.
2003: Pattipati S Naidu; Amanpreet Singh; Dipesh Joshi; Shrinivas K Kulkarni
Possible mechanisms of action in quercetin reversal of morphine tolerance and dependence.
Addiction biology 2003;8(3):327-36.
2003: Vijay Pal Singh; Chandrashekhar S Patil; Naveen K Jain; Amarjit Singh; Shrinivas K Kulkarni
Effect of nimesulide on acetic acid- and leukotriene-induced inflammatory bowel disease in rats.
Prostaglandins & other lipid mediators 2003;71(3-4):163-75.
2003: amanpreet Singh; Gaurav Kumar; Pattipati S Naidu; Shrinivas K Kulkarni
Protective effect of FK506 (tacrolimus) in pentylenetetrazol-induced kindling in mice.
Pharmacology, biochemistry, and behavior 2003;75(4):853-60.
2003: Pattipati S Naidu; amanpreet Singh; Shrinivas K Kulkarni
Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia.
Neuropharmacology 2003;44(8):1100-6.
2003: amanpreet Singh; Pattipati S Naidu; Shrinivas K Kulkarni
Quercetin potentiates L-Dopa reversal of drug-induced catalepsy in rats: possible COMT/MAO inhibition.
Pharmacology 2003;68(2):81-8.
2003: Pattipati S Naidu; amanpreet Singh; Shrinivas K Kulkarni
Reversal of haloperidol-induced orofacial dyskinesia by quercetin, a bioflavonoid.
Psychopharmacology 2003;167(4):418-23.
2003: Vijay Pal Singh; rameshkumar mohanlal gupta; Shrinivas K Kulkarni
Fluoxetine suppresses morphine tolerance and dependence: modulation of NO-cGMP/DA/serotoninergic pathways.
Methods and findings in experimental and clinical pharmacology 2003;25(4):273-80.
2003: rameshkumar mohanlal gupta; Chandrashekhar S Patil; Amarjit Singh; Shrinivas K Kulkarni
Sildenafil, a phosphodiesterase-5 inhibitor, enhances the antinociceptive effect of morphine.
Pharmacology 2003;67(3):150-6.
2003: Pattipati S Naidu; amanpreet Singh; Pushpinder Kaur; Rajat Sandhir; Shrinivas K Kulkarni
Possible mechanism of action in melatonin attenuation of haloperidol-induced orofacial dyskinesia.
Pharmacology, biochemistry, and behavior 2003;74(3):641-8.
2003: amanpreet Singh; Pattipati S Naidu; Chandrashekhar S Patil; Shrinivas K Kulkarni
Effect of FK506 (tacrolimus) in animal models of inflammation.
Inflammopharmacology 2003;11(3):249-57.
2003: Pattipati S Naidu; amanpreet Singh; Shrinivas K Kulkarni
Effect of Withania somnifera root extract on haloperidol-induced orofacial dyskinesia: possible mechanisms of action.
Journal of medicinal food 2003;6(2):107-14.
2003: Gurpreet Kaur; Shrinivas K Kulkarni
Involvement of normal physiological mechanisms in mediation of satiety by polyherbal antiobesity preparation, OB-200G, in female mice.
Methods and findings in experimental and clinical pharmacology 2003;25(1):33-9.
2003: Shrinivas K Kulkarni; Pattipati S Naidu
Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives.
Drugs of today (Barcelona, Spain : 1998) 2003;39(1):19-49.
2002: VN Paul; Kanwaljit Chopra; Shrinivas K Kulkarni
Histaminergic modulation of stress-induced analgesia and cognitive dysfunction.
Methods and findings in experimental and clinical pharmacology 2002;24(7):413-9.
2002: amanpreet Singh; Shrinivas K Kulkarni
Role of adenosine in drug-induced catatonia in mice.
Indian journal of experimental biology 2002;40(8):882-8.
2002: rameshkumar mohanlal gupta; Chandrashekhar S Patil; Shrinivas K Kulkarni; Amarjit Singh
Modulatory role of cyclooxygenase inhibitors in aging- and scopolamine or lipopolysaccharide-induced cognitive dysfunction in mice.
Behavioural brain research 2002;133(2):369-76.
2002: Gurpreet Kaur; Shrinivas K Kulkarni
Evidence for serotonergic modulation of progesterone-induced hyperphagia, depression and algesia in female mice.
Brain research 2002;943(2):206-15.
2002: Pattipati S Naidu; Shrinivas K Kulkarni
Differential effects of cyclooxygenase inhibitors on haloperidol-induced catalepsy.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(5):819-22.
2002: rameshkumar mohanlal gupta; Shrinivas K Kulkarni; Amarjit Singh
Modulation of NSAID-induced antinociceptive and anti-inflammatory effects by alpha2-adrenoceptor agonists with gastroprotective effects.
Life sciences 2002;70(24):2857-69.
2002: Pattipati S Naidu; amanpreet Singh; Shrinivas K Kulkarni
Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms.
British journal of pharmacology 2002;136(2):193-200.
2002: Gurpreet Kaur; Shrinivas K Kulkarni
Studies on modulation of feeding behavior by atypical antipsychotics in female mice.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(2):277-85.
2002: amanpreet Singh; Pattipati S Naidu; Saraswati Gupta; Shrinivas K Kulkarni
Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome.
Journal of medicinal food 2002;5(4):211-20.
2002: amanpreet Singh; Shrinivas K Kulkarni
Nitecapone and selegiline as effective adjuncts to L-DOPA in reserpine-induced catatonia in mice.
Methods and findings in experimental and clinical pharmacology 2002;24(1):23-9.
2001: V P Singh; rameshkumar mohanlal gupta; Shrinivas K Kulkarni
On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor.
Brain research 2001;915(2):218-26.
2001: rameshkumar mohanlal gupta; Shrinivas K Kulkarni; Amanpreet Singh
Lipopolysaccharide-mediated immobility in mice: reversal by cyclooxygenase enzyme inhibitors.
Methods and findings in experimental and clinical pharmacology 2001;23(8):441-4.
2001: Pattipati S Naidu; Shrinivas K Kulkarni
Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.
European journal of pharmacology 2001;428(1):81-6.
2001: rameshkumar mohanlal gupta; Chandrashekhar S Patil; Amarjit Singh; Shrinivas K Kulkarni
Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway.
Brain research 2001;909(1-2):170-8.
2001: rameshkumar mohanlal gupta; Shrinivas K Kulkarni; Amanpreet Singh
Role of cysteinyl leukotrienes in nociceptive and inflammatory conditions in experimental animals.
European journal of pharmacology 2001;423(1):85-92.
2001: V Raghavendra; Pattipati S Naidu; Shrinivas K Kulkarni
Reversal of reserpine-induced vacuous chewing movements in rats by melatonin: involvement of peripheral benzodiazepine receptors.
Brain research 2001;904(1):149-52.
2001: Gurpreet Kaur; Shrinivas K Kulkarni
Differential effect of polyherbal, antiobesity preparation, OB-200G in male and female mice and monosodium glutamate-treated rats.
Indian journal of experimental biology 2001;39(6):551-7.
2001: Pattipati S Naidu; Shrinivas K Kulkarni
Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide.
Behavioural pharmacology 2001;12(3):209-16.
2001: V Raghavendra; Vinod Singh; A V Shaji; Harpreet Vohra; Shrinivas K Kulkarni; Javed N Agrewala
Melatonin provides signal 3 to unprimed CD4(+) T cells but failed to stimulate LPS primed B cells.
Clinical and experimental immunology 2001;124(3):414-22.
2001: Pattipati S Naidu; Shrinivas K Kulkarni
Reversal of neuroleptic-induced orofacial dyskinesia by 5-HT3 receptor antagonists.
European journal of pharmacology 2001;420(2-3):113-7.
2001: V Raghavendra; Vinod Singh; Shrinivas K Kulkarni; Javed N Agrewala
Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists.
Molecular and cellular biochemistry 2001;221(1-2):57-62.
2001: Gurpreet Kaur; Shrinivas K Kulkarni
Subchronic studies on modulation of feeding behavior and body weight by neurosteroids in female mice.
Methods and findings in experimental and clinical pharmacology 2001;23(3):115-9.
2001: Shrinivas K Kulkarni; Pattipati S Naidu
Animal models of tardive dyskinesia--a review.
Indian journal of physiology and pharmacology 2001;45(2):148-60.
2001: V Raghavendra; Shrinivas K Kulkarni
Possible antioxidant mechanism in melatonin reversal of aging and chronic ethanol-induced amnesia in plus-maze and passive avoidance memory tasks.
Free radical biology & medicine 2001;30(6):595-602.
2001: V Raghavendra; Kanwaljit Chopra; Shrinivas K Kulkarni
Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm.
Neuropeptides 2001;35(1):65-9.
2000: V Raghavendra; Shrinivas K Kulkarni
Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice.
European journal of pharmacology 2000;409(3):279-89.
2000: Pattipati S Naidu; Shrinivas K Kulkarni
Differential role of dopamine D1 and D2 receptors in isoniazid-induced vacuous chewing movements.
Methods and findings in experimental and clinical pharmacology 2000;22(10):747-51.
2000: V Raghavendra; G Kaur; Shrinivas K Kulkarni
Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2000;10(6):473-81.
2000: Shrinivas K Kulkarni; Ipe Ninan
Dopamine D4 receptors and development of newer antipsychotic drugs.
Fundamental & clinical pharmacology 2000;14(6):529-39.
2000: VN Paul; Kanwaljit Chopra; Shrinivas K Kulkarni
Modulation of motor functions involving central dopaminergic system by L-histidine.
Indian journal of experimental biology 2000;38(10):988-93.
2000: V Raghavendra; Shrinivas K Kulkarni
AT1 receptor antagonism enhances angiotensin-II-facilitated carrageenan-induced paw edema.
Methods and findings in experimental and clinical pharmacology 2000;22(8):633-6.
2000: Ipe Ninan; Shrinivas K Kulkarni
Ketanserin reverses dizocilpine-suppression of morphine dependence but not tolerance in mice.
Brain research 2000;876(1-2):215-9.
2000: VN Paul; Kanwaljit Chopra; Shrinivas K Kulkarni
Prooxidant role of histidine in hypoxic stressed mice and Fe(3+)-induced lipid peroxidation.
Methods and findings in experimental and clinical pharmacology 2000;22(7):551-5.
2000: Shrinivas K Kulkarni; rameshkumar mohanlal gupta; Amanpreet Singh
Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors.
Methods and findings in experimental and clinical pharmacology 2000;22(5):291-8.
2000: V Raghavendra; Javed N Agrewala; Shrinivas K Kulkarni
Melatonin reversal of lipopolysacharides-induced thermal and behavioral hyperalgesia in mice.
European journal of pharmacology 2000;395(1):15-21.
2000: M Gupta; Shrinivas K Kulkarni
Studies on anticonvulsant actions of L-deprenyl.
Indian journal of experimental biology 2000;38(4):332-7.
2000: V Raghavendra; Shrinivas K Kulkarni
Melatonin reversal of DOI-induced hypophagia in rats; possible mechanism by suppressing 5-HT(2A) receptor-mediated activation of HPA axis.
Brain research 2000;860(1-2):112-8.
2000: B George; Shrinivas K Kulkarni; R Mathur
Motor and electrographic response of refractory experimental status epilepticus in rats and effect of calcium channel blockers.
Indian journal of experimental biology 2000;38(2):105-12.
2000: ANIL KUMAR; rameshkumar mohanlal gupta; Shrinivas K Kulkarni
Analgesic and anti-inflammatory effects of phosphodiesterase inhibitors.
Indian journal of experimental biology 2000;38(1):26-30.
1999: rameshkumar mohanlal gupta; Shrinivas K Kulkarni
Antinociceptive and anti-inflammatory effects of Tanacetum parthenium L. extract in mice and rats.
Journal of ethnopharmacology 1999;68(1-3):251-9.
1999: Ipe Ninan; Shrinivas K Kulkarni
Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
Methods and findings in experimental and clinical pharmacology 1999;21(9):603-8.
1999: C S Patil; Shrinivas K Kulkarni
The morphine sparing effect of physostigmine.
Methods and findings in experimental and clinical pharmacology 1999;21(8):523-7.
1999: V Raghavendra; Shrinivas K Kulkarni
Reversal of morphine tolerance and dependence by melatonin: possible role of central and peripheral benzodiazepine receptors.
Brain research 1999;834(1-2):178-81.
1999: Ipe Ninan; Shrinivas K Kulkarni
Effect of olanzapine on behavioural changes induced by FG 7142 and dizocilpine on active avoidance and plus maze tasks.
Brain research 1999;830(2):337-44.
1999: V Raghavendra; Javed N Agrewala; Shrinivas K Kulkarni
Role of centrally administered melatonin and inhibitors of COX and NOS in LPS-induced hyperthermia and adipsia.
Prostaglandins, leukotrienes, and essential fatty acids 1999;60(4):249-53.
1999: rameshkumar mohanlal gupta; Shrinivas K Kulkarni
L-NAME, a nitric oxide synthase inhibitor, modulates cholinergic antinociception.
Methods and findings in experimental and clinical pharmacology 1999;21(3):161-5.
1999: Ipe Ninan; Shrinivas K Kulkarni
Involvement of dopamine D2 and 5-HT1A receptors in roxindole-induced antinociception.
Indian journal of experimental biology 1999;37(3):234-7.
1999: Ipe Ninan; Shrinivas K Kulkarni
Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine.
European journal of pharmacology 1999;368(1):1-7.
1999: Ipe Ninan; Shrinivas K Kulkarni
Differential effects of olanzapine at dopamine D1 and D2 receptors in dopamine depleted animals.
Psychopharmacology 1999;142(2):175-81.
1999: Ipe Ninan; Shrinivas K Kulkarni
Antagonism by pimozide of olanzapine-induced hypothermia.
Fundamental & clinical pharmacology 1999;13(5):541-6.
1999: V Raghavendra; Kanwaljit Chopra; Shrinivas K Kulkarni
Brain renin angiotensin system (RAS) in stress-induced analgesia and impaired retention.
Peptides 1999;20(3):335-42.
1999: DS Reddy; Shrinivas K Kulkarni
Sex and estrous cycle-dependent changes in neurosteroid and benzodiazepine effects on food consumption and plus-maze learning behaviors in rats.
Pharmacology, biochemistry, and behavior 1999;62(1):53-60.
1998: Ipe Ninan; Shrinivas K Kulkarni
Dopamine receptor sensitive effect of dizocilpine on feeding behaviour.
Brain research 1998;812(1-2):157-63.
1998: Ipe Ninan; Shrinivas K Kulkarni
5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion.
European journal of pharmacology 1998;358(2):111-6.
1998: N K Jain; Shrinivas K Kulkarni
Antinociceptive effect of sumatriptan in mice.
Indian journal of experimental biology 1998;36(10):973-9.
1998: V Raghavendra; Kanwaljit Chopra; Shrinivas K Kulkarni
Involvement of cholinergic system in losartan-induced facilitation of spatial and short-term working memory.
Neuropeptides 1998;32(5):417-21.
1998: DS Reddy; G Kaur; Shrinivas K Kulkarni
Sigma (sigma1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test.
Neuroreport 1998;9(13):3069-73.
1998: DS Reddy; Shrinivas K Kulkarni
Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment.
Brain research 1998;799(2):215-29.
1998: Shrinivas K Kulkarni; P Joseph
Anticonvulsant profile of Siotone granules, a herbal preparation.
Indian journal of experimental biology 1998;36(7):658-62.
1998: Ipe Ninan; Shrinivas K Kulkarni
Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801.
Indian journal of physiology and pharmacology 1998;42(3):375-82.
1998: B George; R Mathur; Shrinivas K Kulkarni
Development of self-sustaining limbic status epilepticus by continuous ventral hippocampal stimulation followed by low dose pilocarpine in rats.
Indian journal of physiology and pharmacology 1998;42(3):359-68.
1998: V Raghavendra; Kanwaljit Chopra; Shrinivas K Kulkarni
Modulation of motor functions involving the dopaminergic system by AT1 receptor antagonist, losartan.
Neuropeptides 1998;32(3):275-80.
1998: B George; Shrinivas K Kulkarni
Protective effect of clozapine against pentylenetetrazol convulsions and kindling.
Methods and findings in experimental and clinical pharmacology 1998;20(5):395-401.
1998: DS Reddy; Shrinivas K Kulkarni
The role of GABA-A and mitochondrial diazepam-binding inhibitor receptors on the effects of neurosteroids on food intake in mice.
Psychopharmacology 1998;137(4):391-400.
1998: D S Reddy; Shrinivas K Kulkarni
Inhibition of neuronal nitric oxide synthase (n-cNOS) reverses the corticotrophin-induced behavioral effects in rats.
Molecular and cellular biochemistry 1998;183(1-2):25-38.
1998: A V Shaji; Shrinivas K Kulkarni
Evidence of GABAergic modulation in melatonin-induced short-term memory deficits and food consumption.
Methods and findings in experimental and clinical pharmacology 1998;20(4):311-9.
1998: DS Reddy; Shrinivas K Kulkarni
The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice.
Brain research 1998;791(1-2):108-16.
1998: Shrinivas K Kulkarni; A V Shaji
Behavioral pharmacology of melatonin.
Methods and findings in experimental and clinical pharmacology 1998;20(3):237-47.
1998: DS Reddy; Shrinivas K Kulkarni
Proconvulsant effects of neurosteroids pregnenolone sulfate and dehydroepiandrosterone sulfate in mice.
European journal of pharmacology 1998;345(1):55-9.
1998: A V Shaji; Shrinivas K Kulkarni
Central nervous system depressant activities of melatonin in rats and mice.
Indian journal of experimental biology 1998;36(3):257-63.
1998: Ipe Ninan; Shrinivas K Kulkarni
Partial agonistic action of clozapine at dopamine D2 receptors in dopamine depleted animals.
Psychopharmacology 1998;135(3):311-7.
1997: DS Reddy; Shrinivas K Kulkarni
Reversal of benzodiazepine inverse agonist FG 7142-induced anxiety syndrome by neurosteroids in mice.
Methods and findings in experimental and clinical pharmacology 1997;19(10):665-81.
1997: DS Reddy; Shrinivas K Kulkarni
Chronic neurosteroid treatment prevents the development of morphine tolerance and attenuates abstinence behavior in mice.
European journal of pharmacology 1997;337(1):19-25.
1997: B George; Shrinivas K Kulkarni
Dopaminergic modulation of lithium/pilocarpine-induced status epilepticus in rats.
Methods and findings in experimental and clinical pharmacology 1997;19(7):481-8.
1997: Shrinivas K Kulkarni; Ipe Ninan
Inhibition of morphine tolerance and dependence by Withania somnifera in mice.
Journal of ethnopharmacology 1997;57(3):213-7.
1997: DS Reddy; Shrinivas K Kulkarni
Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity in mice.
Methods and findings in experimental and clinical pharmacology 1997;19(6):395-405.
1997: B George; Shrinivas K Kulkarni
Modulation of lithium-pilocarpine-induced status epilepticus by adenosinergic agents.
Methods and findings in experimental and clinical pharmacology 1997;19(5):329-33.
1997: DS Reddy; Shrinivas K Kulkarni
Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice.
Brain research 1997;752(1-2):61-71.
1997: M Roychoudhury; Shrinivas K Kulkarni
Antianxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model.
Methods and findings in experimental and clinical pharmacology 1997;19(2):107-11.
1997: M Roychoudhury; Shrinivas K Kulkarni
Effects of ondansetron on short-term memory retrieval in mice.
Methods and findings in experimental and clinical pharmacology 1997;19(1):43-6.
1996: M Roychoudhury; Shrinivas K Kulkarni
Prevention of morphine discontinuation phenomenon in mice by ondansetron, a selective 5-HT3 antagonist.
Methods and findings in experimental and clinical pharmacology 1996;18(10):677-83.
1996: Shrinivas K Kulkarni; Rajesh Goel
Gastric antiulcer activity of UL-409 in rats.
Indian journal of experimental biology 1996;34(7):683-8.
1996: Ipe Ninan; Shrinivas K Kulkarni
Clozapine-induced cognitive dysfunction in mice.
Methods and findings in experimental and clinical pharmacology 1996;18(6):367-72.
1996: B George; Shrinivas K Kulkarni
Protective effects of GABAergic drugs and other anticonvulsants in lithium-pilocarpine-induced status epilepticus.
Methods and findings in experimental and clinical pharmacology 1996;18(5):335-40.
1996: Shrinivas K Kulkarni; DS Reddy
Animal behavioral models for testing antianxiety agents.
Methods and findings in experimental and clinical pharmacology 1996;18(3):219-30.
1995: Shrinivas K Kulkarni; B George
Lithium-pilocarpine neurotoxicity: a potential model of status epilepticus.
Methods and findings in experimental and clinical pharmacology 1995;17(8):551-67.
1995: A Verma; Shrinivas K Kulkarni
N-Methyl-D-aspartate receptor participation in Parkinson's disease, a neurodegenerative disorder.
Annals of the New York Academy of Sciences 1995;765():327.
1995: Shrinivas K Kulkarni; B George
Pentylenetetrazol-induced kindling in animals: protective effect of BR-16A.
Indian journal of experimental biology 1995;33(6):424-7.
1995: A Verma; Shrinivas K Kulkarni
Role of D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptors in morphine tolerance and dependence in mice.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1995;5(2):81-7.
1994: Shrinivas K Kulkarni; A Sharma
Reversal of diazepam withdrawal induced hyperactivity in mice by BR 16-A (Mentat), a herbal preparation.
Indian journal of experimental biology 1994;32(12):886-8.
1994: Shrinivas K Kulkarni; B George
Kindling model of epilepsy.
Methods and findings in experimental and clinical pharmacology 1994;16(10):735-45.
1994: Shrinivas K Kulkarni; A Sharma
Rat anococcygeus: a dynamic smooth muscle preparation for experimental pharmacology.
Methods and findings in experimental and clinical pharmacology 1994;16(6):379-85.
1994: A Sharma; Shrinivas K Kulkarni
On the characterization of dopamine-induced contractile response of rat anococcygeus muscle preparation.
Indian journal of experimental biology 1994;32(3):176-9.
1994: A Sharma; Shrinivas K Kulkarni
Dopamine receptor mediated antidepressant action of B-HT 920 in mice.
Indian journal of experimental biology 1994;32(3):172-5.
1993: Shrinivas K Kulkarni; K Sharma
Alprazolam modifies animal behaviour on elevated plus-maze.
Indian journal of experimental biology 1993;31(11):908-11.
1993: A Verma; Shrinivas K Kulkarni; U Nayar
Effect of D1- and D2-dopamine agonists on neocortical and hippocampal EEG activity of rat brain: modulation of rimcazole effect.
Methods and findings in experimental and clinical pharmacology 1993;15(8):515-25.
1993: A Verma; Shrinivas K Kulkarni
Differential role of dopamine receptor subtypes in thermoregulation and stereotypic behavior in naive and reserpinized rats.
Archives internationales de pharmacodynamie et de thérapie 1993;324():17-32.
1993: Shrinivas K Kulkarni; A Verma
Protective effect of BR-16A (Mentat), a herbal preparation on alcohol abstinence-induced anxiety and convulsions.
Indian journal of experimental biology 1993;31(5):435-9.
1993: Avadhesh C Sharma; Shrinivas K Kulkarni
(+/-)Baclofen sensitive scopolamine-induced short-term memory deficits in mice.
Indian journal of experimental biology 1993;31(4):348-52.
1993: Avadhesh C Sharma; Shrinivas K Kulkarni
Evidence for benzodiazepine receptor interaction with MK 801 in anxiety related behaviour in rats.
Indian journal of experimental biology 1993;31(2):191-3.
1992: Shrinivas K Kulkarni; A Verma
Prevention of development of tolerance and dependence to opiate in mice by BR-16A (Mentat), a herbal psychotropic preparation.
Indian journal of experimental biology 1992;30(10):885-8.
1992: Shrinivas K Kulkarni; A Verma
Evidence for nootropic effect of BR-16A (Mentat), a herbal psychotropic preparation, in mice.
Indian journal of physiology and pharmacology 1992;36(1):29-34.
1992: Avadhesh C Sharma; Shrinivas K Kulkarni
Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and mice.
Progress in neuro-psychopharmacology & biological psychiatry 1992;16(1):117-25.
1992: A Verma; Shrinivas K Kulkarni
D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats.
Psychopharmacology 1992;109(4):477-83.
1992: A Verma; Shrinivas K Kulkarni
Modulation of MK-801 response by dopaminergic agents in mice.
Psychopharmacology 1992;107(2-3):431-6.
1991: A Verma; Shrinivas K Kulkarni
Effect of a herbal psychotropic preparation, BR-16A (Mentat), on performance of mice on elevated plus-maze.
Indian journal of experimental biology 1991;29(12):1120-3.
1991: K O Aley; Shrinivas K Kulkarni
Baclofen analgesia in mice: a GABAB-mediated response.
Methods and findings in experimental and clinical pharmacology 1991;13(10):681-6.
1991: A Verma; Shrinivas K Kulkarni
Chronic electroconvulsive shock alters hypothermic response of B-HT 920 and SKF 38393 in rats.
The Journal of pharmacy and pharmacology 1991;43(11):813-4.
1991: Shrinivas K Kulkarni; Avadhesh C Sharma
Elevated plus-maze: a novel psychobehavioral tool to measure anxiety in rodents.
Methods and findings in experimental and clinical pharmacology 1991;13(8):573-7.
1991: Avadhesh C Sharma; Shrinivas K Kulkarni; U Nayar
Effect of NMDA-receptor ligands on neocortical and hippocampal EEG activity of rat brain.
Indian journal of experimental biology 1991;29(8):744-50.
1991: S N Thorat; Shrinivas K Kulkarni
Antagonism of caffeine-induced convulsions by ethanol and dizocilpine (MK-801) in mice.
Methods and findings in experimental and clinical pharmacology 1991;13(6):413-7.
1991: S K Gautam; Shrinivas K Kulkarni
GABA/BZ-and NMDA-receptor interaction in digoxin-induced convulsions in rats.
Indian journal of experimental biology 1991;29(7):636-40.
1991: A Verma; Shrinivas K Kulkarni
Dopamine receptor mediated hypothermic action of B-HT 920 in rats.
The Journal of pharmacy and pharmacology 1991;43(6):421-4.
1991: Avadhesh C Sharma; S N Thorat; U Nayar; Shrinivas K Kulkarni
Dizocilpine, ketamine and ethanol reverse NMDA-induced EEG changes and convulsions in rats and mice.
Indian journal of physiology and pharmacology 1991;35(2):111-6.
1991: Avadhesh C Sharma; Shrinivas K Kulkarni
Effects of MK-801 and ketamine on short-term memory deficits in passive avoidance step-down task paradigm in mice.
Methods and findings in experimental and clinical pharmacology 1991;13(3):155-9.
1991: K O Aley; Shrinivas K Kulkarni
Altered response to GABAergic agents following electro and chemo convulsions in mice.
Indian journal of experimental biology 1991;29(3):241-3.
1991: A Verma; Shrinivas K Kulkarni
Concomitant D1 dopamine receptor activation (SKF 38393) unmasks D2 dopaminergic actions of B-HT 920 in mice.
Indian journal of experimental biology 1991;29(2):123-6.
1991: A Verma; Shrinivas K Kulkarni
Alpha 2-adrenoceptor- and D2-dopamine receptor-mediated analgesic response of B-HT 920.
The Journal of pharmacy and pharmacology 1991;43(2):131-3.
1990: S N Thorat; Shrinivas K Kulkarni
Benzodiazepine inverse agonist, DMCM- and peripheral agonist, Ro 5-4864-induced convulsions in mice: effect of adenosinergic agents.
Indian journal of experimental biology 1990;28(12):1160-5.
1990: K O Aley; Shrinivas K Kulkarni; R Mathur; U Nayar
Effect of chronic treatment of Ro 15-1788 and its withdrawal on cortical and hippocampal EEG activity in rats.
Indian journal of experimental biology 1990;28(12):1149-59.
1990: S N Thorat; Shrinivas K Kulkarni
Effect of MK-801 and its interaction with adenosinergic agents and carbamazepine against hypoxic stress-induced convulsions and death in mice.
Methods and findings in experimental and clinical pharmacology 1990;12(9):595-600.
1990: K O Aley; Shrinivas K Kulkarni
Effect of baclofen, a GABAB-agonist, on forced swimming-induced immobility in mice.
Archives internationales de pharmacodynamie et de thérapie 1990;307():18-31.
1990: Avadhesh C Sharma; Shrinivas K Kulkarni
Evidence for GABA-BZ receptor modulation in short-term memory passive avoidance task paradigm in mice.
Methods and findings in experimental and clinical pharmacology 1990;12(3):175-80.
1990: Shrinivas K Kulkarni; K Chopra
The dopaminergic actions of B-HT 920.
Methods and findings in experimental and clinical pharmacology 1990;12(2):99-102.
1990: S N Thorat; Shrinivas K Kulkarni
The protective effect of adenosinergic agents, Ro 5-4864 and carbamazepine against hypoxic stress-induced neurotoxicity in mice.
Methods and findings in experimental and clinical pharmacology 1990;12(1):17-22.
1989: K O Aley; Shrinivas K Kulkarni
GABAergic agents-induced antinociceptive effect in mice.
Methods and findings in experimental and clinical pharmacology 1989;11(10):597-601.
1989: K O Aley; Shrinivas K Kulkarni
GABAergic agents and clonidine attenuate footshock-induced aggression in mice.
Methods and findings in experimental and clinical pharmacology 1989;11(9):541-5.
1989: V K Shukla; A K Sethi; S K Garg; Nirmal Kumar Ganguly; Shrinivas K Kulkarni
Effect of venoruton on hypoxic stress-induced neurotoxicity in mice and oxygen free radical generation by human neutrophils.
Archives internationales de pharmacodynamie et de thérapie 1989;299():127-33.
1989: K O Aley; Shrinivas K Kulkarni
GABA-mediated modification of despair behavior in mice.
Naunyn-Schmiedeberg's archives of pharmacology 1989;339(3):306-11.
1988: K O Aley; Shrinivas K Kulkarni
Studies on the neuropsychopharmacological profile of fengabine (SL 79229) in mice.
Methods and findings in experimental and clinical pharmacology 1988;10(9):563-8.
1988: K Chopra; Shrinivas K Kulkarni
Potentiation of dopamine receptor-mediated responses by B-HT 920 in mice.
Archives internationales de pharmacodynamie et de thérapie 1988;294():46-55.
1988: K Chopra; J Kunchandy; Shrinivas K Kulkarni
Benzodiazepine inverse agonist FG-7142-induced delayed behavioral depression in mice.
Archives internationales de pharmacodynamie et de thérapie 1988;294():56-63.
1988: K O Aley; Shrinivas K Kulkarni
Anticatatonic effect of venoruton.
Methods and findings in experimental and clinical pharmacology 1988;10(4):263-5.
1988: J Kunchandy; Shrinivas K Kulkarni
Hypoxic stress-induced convulsion and death: protective effect of alpha 2-adrenoceptor and benzodiazepine receptor agonists and Ro 5-4864.
Archives internationales de pharmacodynamie et de thérapie 1988;292():35-44.
1988: S N Thorat; Shrinivas K Kulkarni
Involvement of postsynaptic adrenergic mechanism(s) in the ATP-contractions of the rat anococcygeus muscle and the effect of extracellular Ca2+.
Archives internationales de pharmacodynamie et de thérapie 1988;291():104-12.
1987: K O Aley; Shrinivas K Kulkarni
Studies on meperidine-induced catalepsy in mice.
Methods and findings in experimental and clinical pharmacology 1987;9(8):493-6.